Advertisement
News
Advertisement

Galenea shares $3M grant for schizophrenia research

Fri, 09/07/2012 - 12:00am
Mass High Tech: The Journal of New England Technology

Researchers at Galenea Corp. will share a five-year, $3 million grant from the National Institute of Mental Health (NIMH) with Kevin Spencer of the VA Boston Healthcare System and Harvard Medical School to develop new biomarkers to measure the effectiveness of drugs aimed at schizophrenia.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading